FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3103242011> ?p ?o ?g. }

• W3103242011 abstract "Objective: To compare the clinical and neuroimaging characteristics of anti-myelin oligodendrocyte glycoprotein antibody (MOG-ab) negative and positive pediatric acute disseminating encephalomyelitis (ADEM) patients. Methods: Clinical characteristics, neuroimaging features, ancillary examination results, and outcomes of pediatric ADEM patients were retrospectively reviewed between February 2016 and July 2019. Results: Among 37 pediatric ADEM patients, 24 patients (11 girls and 13 boys) fulfilled the inclusion criteria. The median age was 72 (range 19–156) months, and the median follow-up duration was 20 (range 12–48) months. Children with ADEM and MOG-abs presented with increased ataxia, reduced bladder/rectum dysfunction, and paralysis compared to children without MOG-abs. An important finding was that no significant differences existed in age at symptom onset, sex ratio, time from immunotherapy to clinical improvement and clinical recovery, or modified Rankin Scale (mRS) at the last follow-up. More typical cerebral MRI lesions were detected in patients with ADEM and MOG-abs than in children without MOG-abs [11/12 (91.7%) vs. 8/12 (66.7%)]. Cerebellar lesions were higher in ADEM patients with MOG-abs (7/12, 58.3%) than in those without MOG-abs (2/12, 16.7%). While seven children had abnormal spinal MRI findings (7/12, 58.3%) and five had longitudinally extensive transverse myelitis (LETM) (5/12, 41.7%) per group, the coexistence of spinal dysfunction and abnormal spinal MRI was lower in ADEM with MOG-abs (2/12, 16.7%) than in children without MOG-abs (7/12, 58.3%). Clinical improvement was achieved 1 week after immunotherapy. Most children in both groups achieved clinical recovery within 3 months after immunotherapy, although two (16.7%) patients with ADEM and MOG-abs had persistent neurological sequelae at the last follow-up. Conclusion: MOG-abs-positive ADEM is a major subtype of pediatric ADEM. Ataxia is the most common clinical presentation in pediatric ADEM and MOG-abs. Children with ADEM and MOG-abs have similar patterns of lesions characterized by large, bilateral, widespread lesions, as well as more cerebellar lesions than children without MOG-abs. Most spinal lesions were subclinical in pediatric ADEM with MOG-abs. A favorable prognosis can be achieved for pediatric ADEM regardless of the MOG-abs status. However, some patients with MOG-abs are likely to have more severe neurological sequelae." @default.
• W3103242011 created "2020-11-23" @default.
• W3103242011 creator A5018100580 @default.
• W3103242011 creator A5020764842 @default.
• W3103242011 creator A5024575885 @default.
• W3103242011 creator A5033763955 @default.
• W3103242011 creator A5037014608 @default.
• W3103242011 creator A5050542940 @default.
• W3103242011 creator A5053204257 @default.
• W3103242011 creator A5066983840 @default.
• W3103242011 creator A5073046398 @default.
• W3103242011 date "2020-11-20" @default.
• W3103242011 modified "2023-10-03" @default.
• W3103242011 title "Clinical and Neuroimaging Characteristics of Pediatric Acute Disseminating Encephalomyelitis With and Without Antibodies to Myelin Oligodendrocyte Glycoprotein" @default.
• W3103242011 cites W1005758705 @default.
• W3103242011 cites W1966999661 @default.
• W3103242011 cites W1975780052 @default.
• W3103242011 cites W1987115587 @default.
• W3103242011 cites W2005645667 @default.
• W3103242011 cites W2007502293 @default.
• W3103242011 cites W2021865068 @default.
• W3103242011 cites W2025358672 @default.
• W3103242011 cites W2055514366 @default.
• W3103242011 cites W2116294933 @default.
• W3103242011 cites W2128236724 @default.
• W3103242011 cites W2292586334 @default.
• W3103242011 cites W2345985251 @default.
• W3103242011 cites W2367900844 @default.
• W3103242011 cites W2739773649 @default.
• W3103242011 cites W2751963214 @default.
• W3103242011 cites W2767386734 @default.
• W3103242011 cites W2770558705 @default.
• W3103242011 cites W2782439756 @default.
• W3103242011 cites W2786802845 @default.
• W3103242011 cites W2791030344 @default.
• W3103242011 cites W2902875551 @default.
• W3103242011 cites W2912407698 @default.
• W3103242011 cites W2918193821 @default.
• W3103242011 cites W2945083001 @default.
• W3103242011 cites W2955939718 @default.
• W3103242011 cites W2962171619 @default.
• W3103242011 cites W2964023255 @default.
• W3103242011 cites W2965728698 @default.
• W3103242011 cites W3038260603 @default.
• W3103242011 doi "https://doi.org/10.3389/fneur.2020.593287" @default.
• W3103242011 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7717994" @default.
• W3103242011 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33329345" @default.
• W3103242011 hasPublicationYear "2020" @default.
• W3103242011 type Work @default.
• W3103242011 sameAs 3103242011 @default.
• W3103242011 citedByCount "10" @default.
• W3103242011 countsByYear W31032420112021 @default.
• W3103242011 countsByYear W31032420112022 @default.
• W3103242011 countsByYear W31032420112023 @default.
• W3103242011 crossrefType "journal-article" @default.
• W3103242011 hasAuthorship W3103242011A5018100580 @default.
• W3103242011 hasAuthorship W3103242011A5020764842 @default.
• W3103242011 hasAuthorship W3103242011A5024575885 @default.
• W3103242011 hasAuthorship W3103242011A5033763955 @default.
• W3103242011 hasAuthorship W3103242011A5037014608 @default.
• W3103242011 hasAuthorship W3103242011A5050542940 @default.
• W3103242011 hasAuthorship W3103242011A5053204257 @default.
• W3103242011 hasAuthorship W3103242011A5066983840 @default.
• W3103242011 hasAuthorship W3103242011A5073046398 @default.
• W3103242011 hasBestOaLocation W31032420111 @default.
• W3103242011 hasConcept C118552586 @default.
• W3103242011 hasConcept C126322002 @default.
• W3103242011 hasConcept C142724271 @default.
• W3103242011 hasConcept C187212893 @default.
• W3103242011 hasConcept C203014093 @default.
• W3103242011 hasConcept C2777185649 @default.
• W3103242011 hasConcept C2777899865 @default.
• W3103242011 hasConcept C2778486448 @default.
• W3103242011 hasConcept C2779328510 @default.
• W3103242011 hasConcept C2779357208 @default.
• W3103242011 hasConcept C2780640218 @default.
• W3103242011 hasConcept C2780892749 @default.
• W3103242011 hasConcept C2781137167 @default.
• W3103242011 hasConcept C58693492 @default.
• W3103242011 hasConcept C71924100 @default.
• W3103242011 hasConceptScore W3103242011C118552586 @default.
• W3103242011 hasConceptScore W3103242011C126322002 @default.
• W3103242011 hasConceptScore W3103242011C142724271 @default.
• W3103242011 hasConceptScore W3103242011C187212893 @default.
• W3103242011 hasConceptScore W3103242011C203014093 @default.
• W3103242011 hasConceptScore W3103242011C2777185649 @default.
• W3103242011 hasConceptScore W3103242011C2777899865 @default.
• W3103242011 hasConceptScore W3103242011C2778486448 @default.
• W3103242011 hasConceptScore W3103242011C2779328510 @default.
• W3103242011 hasConceptScore W3103242011C2779357208 @default.
• W3103242011 hasConceptScore W3103242011C2780640218 @default.
• W3103242011 hasConceptScore W3103242011C2780892749 @default.
• W3103242011 hasConceptScore W3103242011C2781137167 @default.
• W3103242011 hasConceptScore W3103242011C58693492 @default.
• W3103242011 hasConceptScore W3103242011C71924100 @default.
• W3103242011 hasLocation W31032420111 @default.
• W3103242011 hasLocation W31032420112 @default.
• W3103242011 hasOpenAccess W3103242011 @default.
• W3103242011 hasPrimaryLocation W31032420111 @default.
• W3103242011 hasRelatedWork W1508255314 @default.

• next